Document is current

Any future updates will be listed below

Correction: Cardiorenal effectiveness of empagliflozin vs. glucagon-like peptide-1 receptor agonists: final-year results from the EMPRISE study

Crossref DOI link: https://doi.org/10.1186/s12933-024-02190-6

Published Online: 2024-03-18

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark